PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 1.140
-0.055 (-4.60%)
Nov 14, 2025, 10:09 AM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 825.56 million as of November 13, 2025. Its market cap has decreased by -41.98% in one year.
Market Cap
825.56M
Enterprise Value
809.11M
Revenue
128.70M
Ranking
n/a
PE Ratio
63.23
Stock Price
1.14
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 825.56M, an increase of 2,395.10%. That is a compound annual growth rate of 13.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 825.56M | -41.42% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | 2.57B | 96.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.55B |
| Pro Medicus | 26.88B |
| Cochlear | 18.75B |
| Sonic Healthcare | 10.44B |
| Ramsay Health Care | 7.08B |
| Telix Pharmaceuticals | 5.29B |
| Ansell | 5.24B |
| Mesoblast | 2.96B |